In the preliminary study, our group validated that the expression of RBM5 is lower in human lung cancer tissues than normal tissues did [11], the overexpression of RBM5 inhibit the proliferation and induce the apoptosis of human lung cancer A549 cells [15]. Here, RBM5 is linked to lung carcinoma.